These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 34659037)

  • 41. Psilocybin-Mediated Attenuation of Gamma Band Auditory Steady-State Responses (ASSR) Is Driven by the Intensity of Cognitive and Emotional Domains of Psychedelic Experience.
    Viktorin V; Griškova-Bulanova I; Voicikas A; Dojčánová D; Zach P; Bravermanová A; Andrashko V; Tylš F; Korčák J; Viktorinová M; Koudelka V; Hájková K; Kuchař M; Horáček J; Brunovský M; Páleníček T
    J Pers Med; 2022 Jun; 12(6):. PubMed ID: 35743788
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Serotonergic psychedelics LSD & psilocybin increase the fractal dimension of cortical brain activity in spatial and temporal domains.
    Varley TF; Carhart-Harris R; Roseman L; Menon DK; Stamatakis EA
    Neuroimage; 2020 Oct; 220():117049. PubMed ID: 32619708
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bibliometric Analysis of Academic Journal Articles Reporting Results of Psychedelic Clinical Studies.
    Weleff J; Akiki TJ; Barnett BS
    J Psychoactive Drugs; 2023; 55(4):434-444. PubMed ID: 36218281
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Psychedelics and Neuroplasticity: A Systematic Review Unraveling the Biological Underpinnings of Psychedelics.
    de Vos CMH; Mason NL; Kuypers KPC
    Front Psychiatry; 2021; 12():724606. PubMed ID: 34566723
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Knowledge, Perceptions, and Use of Psychedelics among Individuals with Fibromyalgia.
    Glynos NG; Pierce J; Davis AK; McAfee J; Boehnke KF
    J Psychoactive Drugs; 2023; 55(1):73-84. PubMed ID: 35001856
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Investigation of self-treatment with lysergic acid diethylamide and psilocybin mushrooms: Findings from the Global Drug Survey 2020.
    Kopra EI; Ferris JA; Winstock AR; Kuypers KP; Young AH; Rucker JJ
    J Psychopharmacol; 2023 Jul; 37(7):733-748. PubMed ID: 36876583
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Safety and Efficacy of Psychedelic-Assisted Therapies for Older Adults: Knowns and Unknowns.
    Johnston CB; Mangini M; Grob C; Anderson B
    Am J Geriatr Psychiatry; 2023 Jan; 31(1):44-53. PubMed ID: 36184377
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Zoon politikon: The evolutionary origins of human socio-political systems.
    Gintis H; van Schaik C; Boehm C
    Behav Processes; 2019 Apr; 161():17-30. PubMed ID: 29581024
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Analysis of Psilocybin-Assisted Therapy in Medicine: A Narrative Review.
    Ziff S; Stern B; Lewis G; Majeed M; Gorantla VR
    Cureus; 2022 Feb; 14(2):e21944. PubMed ID: 35273885
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A journey with psychedelic mushrooms: From historical relevance to biology, cultivation, medicinal uses, biotechnology, and beyond.
    Pepe M; Hesami M; de la Cerda KA; Perreault ML; Hsiang T; Jones AMP
    Biotechnol Adv; 2023 Dec; 69():108247. PubMed ID: 37659744
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dietary change among hominins and cercopithecids in Ethiopia during the early Pliocene.
    Levin NE; Haile-Selassie Y; Frost SR; Saylor BZ
    Proc Natl Acad Sci U S A; 2015 Oct; 112(40):12304-9. PubMed ID: 26371308
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The biology of the colonizing ape.
    Wells JC; Stock JT
    Am J Phys Anthropol; 2007; Suppl 45():191-222. PubMed ID: 18046751
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Adverse events in clinical treatments with serotonergic psychedelics and MDMA: A mixed-methods systematic review.
    Breeksema JJ; Kuin BW; Kamphuis J; van den Brink W; Vermetten E; Schoevers RA
    J Psychopharmacol; 2022 Oct; 36(10):1100-1117. PubMed ID: 36017784
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The acute effects of classic psychedelics on memory in humans.
    Healy CJ
    Psychopharmacology (Berl); 2021 Mar; 238(3):639-653. PubMed ID: 33420592
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Psychedelic drug abuse potential assessment for new drug applications and controlled substance scheduling: A United States perspective.
    Henningfield JE; Ashworth J; Heal DJ; Smith SL
    J Psychopharmacol; 2023 Jan; 37(1):33-44. PubMed ID: 36588452
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Psychedelic Psychiatry and the Consult-Liaison Psychiatrist: A Primer.
    Barnett BS; Greer GR
    J Acad Consult Liaison Psychiatry; 2021; 62(4):460-471. PubMed ID: 34210406
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Psychedelics for the treatment of depression, anxiety, and existential distress in patients with a terminal illness: a systematic review.
    Schimmers N; Breeksema JJ; Smith-Apeldoorn SY; Veraart J; van den Brink W; Schoevers RA
    Psychopharmacology (Berl); 2022 Jan; 239(1):15-33. PubMed ID: 34812901
    [TBL] [Abstract][Full Text] [Related]  

  • 58. An Assessment of Psychedelic Knowledge Among People Using Psychedelics Naturalistically.
    Kruger DJ; Glynos NG; Fields CW; Herberholz M; Boehnke KF
    J Psychoactive Drugs; 2023; 55(4):420-424. PubMed ID: 36328419
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Psychedelics as a Treatment for Alzheimer's Disease Dementia.
    Vann Jones SA; O'Kelly A
    Front Synaptic Neurosci; 2020; 12():34. PubMed ID: 32973482
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.